Ulcerative Colitis Newswire

Ulcerative Colitis Newswire

Comprehensive Real-Time News Feed for Ulcerative Colitis.

Results 1 - 20 of 1,417 in Ulcerative Colitis

  1. IBD vs. IBS: What's the Difference?Read the original story

    1 hr ago | HealthCentral

    ... eat a food that triggers your symptoms. IBD is the umbrella term for two conditions: Crohn's disease and ulcerative colitis . These conditions are chronic, lifelong diseases in which the intestinal tract is inflamed or ulcerated. IBD, while ...

    Comment?

  2. Innovate Biopharmaceuticals (INNT) Earns Buy Rating from Analysts at HC WainwrightRead the original story w/Photo

    8 hrs ago | IntersportsWire

    ... disease. It also develops INN-108, which has completed Phase 1 clinical trial to treat mild-to-moderate ulcerative colitis; INN-217 for the treatment of non-alcoholic steatohepatitis and microbiome; and INN-289 to treat crohn's disease. Receive ...

    Comment?

  3. Novel insights on 'leaky' gutRead the original story w/Photo

    12 hrs ago | PhysOrg Weblog

    ... of compromised epithelial barrier function. More importantly, BVES mRNA levels were reduced in human ulcerative colitis biopsy specimens. These findings suggest that BVES plays a protective role in ulcerative and infectious colitis and highlights ...

    Comment?

  4. 'Bursting point' in row over public loosRead the original story w/Photo

    18 hrs ago | BBC News

    ... He says: "I used to drive fish lorries and for a period of my life 15 years ago I had chronic bout of ulcerative colitis and I depended on public toilets a lot. Highland Council accepts that mistakes have been made in the process, but insists that ...

    Comment?

  5. Galapagos NV/S (GLPG) Expected to Post Earnings of -$0.91 Per ShareRead the original story w/Photo

    22 hrs ago | AmericanBankingNews.com

    ... clinical trials for the treatment of rheumatoid arthritis and Crohn's disease, Phase 2/3 trials for ulcerative colitis, and Phase II trials for multiple additional indications; GLPG1690, an autotaxin inhibitor, which is in Phase III clinical ...

    Comment?

  6. Immune Pharmaceuticals (IMNP) Stock Price Down 13.6%Read the original story w/Photo

    Thursday | IntersportsWire

    ... which is in Phase II clinical trials that targets eotaxin-1 for the treatment of bullous pemphigoid and ulcerative colitis. Receive News & Ratings for Immune Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary ...

    Comment?

  7. Galapagos NV/S (GLPG) Stock Rating Upgraded by Zacks Investment ResearchRead the original story w/Photo

    Wednesday Jul 18 | Daily Political

    ... clinical trials for the treatment of rheumatoid arthritis and Crohn's disease, Phase 2/3 trials for ulcerative colitis, and Phase II trials for multiple additional indications; GLPG1690, an autotaxin inhibitor, which is in Phase III clinical ...

    Comment?

  8. Innovate Biopharmaceuticals Inc (INNT) Given Consensus Recommendation ...Read the original story w/Photo

    Wednesday | AmericanBankingNews.com

    ... disease. It also develops INN-108, which has completed Phase 1 clinical trial to treat mild-to-moderate ulcerative colitis; INN-217 for the treatment of non-alcoholic steatohepatitis and microbiome; and INN-289 to treat crohn's disease. Receive ...

    Comment?

  9. Dear Society: A Letter From a UC PatientRead the original story

    Wednesday | HealthCentral

    ... about you , per se. It's about me and a bunch of my friends who are just your average people living with ulcerative colitis (UC ), a chronic illness of the digestive system. There are about 100,000 people in the United States living with UC, so you ...

    Comment?

  10. Glycopyrrolate Injection, USP Now Available from Fresenius KabiRead the original story w/Photo

    Wednesday Jul 18 | The Galveston County Daily News

    ... atony of the elderly or debilitated patient; unstable cardiovascular status in acute hemorrhage; severe ulcerative colitis; toxic megacolon complicating ulcerative colitis; myasthenia gravis. Benzyl Alcohol: Exposure to excessive amounts of benzyl ...

    Comment?

  11. What does it mean when your poop is stringy?Read the original story w/Photo

    Wednesday Jul 18 | Medical News Today

    ... e, including risk factors and management. This MNT Knowledge Center article discusses the two main types: Ulcerative colitis and Crohn's disease. Bowel movements may be embarrassing to bring up, but they provide a vital insight into the state

    Comment?

  12. Protagonist Therapeutics Inc (PTGX) Shares Sold by Franklin Street Advisors Inc. NCRead the original story w/Photo

    Tuesday Jul 17 | IntersportsWire

    ... an oral alpha-4-beta-7 integrin- antagonist that is in Phase II b clinical trial for the treatment of ulcerative colitis, as well as for treating chronic pouchitis, a gastrointestinal (GI) condition that occurs in post-surgical inflammatory bowel ...

    Comment?

  13. Galapagos NV/S (GLPG) Price Target Raised to $126.00Read the original story w/Photo

    Tuesday Jul 17 | IntersportsWire

    ... clinical trials for the treatment of rheumatoid arthritis and Crohn's disease, Phase 2/3 trials for ulcerative colitis, and Phase II trials for multiple additional indications; GLPG1690, an autotaxin inhibitor, which is in Phase III clinical ...

    Comment?

  14. Short Interest in Innovate Biopharmaceuticals Inc (INNT) Increases By 101.6%Read the original story w/Photo

    Tuesday Jul 17 | IntersportsWire

    ... disease. It also develops INN-108, which has completed Phase 1 clinical trial to treat mild-to-moderate ulcerative colitis; INN-217 for the treatment of non-alcoholic steatohepatitis and microbiome; and INN-289 to treat crohn's disease. Receive ...

    Comment?

  15. Trivedi Global, Inc. and Joy Angevin Balmer Announce the Research...Read the original story w/Photo

    Dec 8, 2016 | PRWeb

    ... Multiple Sclerosis (MS), Tuberculosis, Rheumatoid arthritis, Chronic periodontitis, Crohn's disease, Ulcerative colitis, Lupus, Vitiligo, Hashimoto Thyroiditis, Chronic sinusitis, Type 1 Diabetes, Asthma, Rheumatoid Arthritis, Sjogren Syndrome, ...

    Comment?

  16. Darren Fletcher could miss Manchester United's pre-season if broken toe requires surgeryRead the original story w/Photo

    Jun 10, 2014 | Daily Mail

    ... is desperate to get a full close season of preparation under his belt after making a full recovery from ulcerative colitis which had threatened to end his career and troubled him for more than two years. Fletcher made 12 appearances after his return ...

    Comment?

  17. Galapagos NV/S (GLPG) Receives $113.60 Average Target Price from BrokeragesRead the original story w/Photo

    Monday Jul 16 | IntersportsWire

    ... clinical trials for the treatment of rheumatoid arthritis and Crohn's disease, Phase 2/3 trials for ulcerative colitis, and Phase II trials for multiple additional indications; GLPG1690, an autotaxin inhibitor, which is in Phase III clinical ...

    Comment?

  18. Karen Telleen-Lawton: 'The Good Gut' with Drs. Erica and Justin SonnenburgRead the original story w/Photo

    Monday Jul 16 | Noozhawk

    ... range from annoying seasonal allergies and eczema to serious chronic conditions such as Crohn's disease, ulcerative colitis and multiple schlerosis. Attacking the microbiota with antibiotics also correlates with an increased risk of developing ...

    Comment?

  19. Targeting one hormone may help treat bowel cancerRead the original story w/Photo

    Monday Jul 16 | Medical News Today

    ... disease , which can inflame any part of the gastrointestinal tract between the mouth and the anus; and ulcerative colitis, which mainly affects the colon. A study finds that intestinal fungi, as well as bacteria, are important for gut health and ...

    Comment?

  20. -$0.62 Earnings Per Share Expected for Arena Pharmaceuticals, Inc. (ARNA) This QuarterRead the original story w/Photo

    Sunday Jul 15 | AmericanBankingNews.com

    ... that is in Phase II trials for treating immune and inflammatory conditions with primary focus on ulcerative colitis and hepatic conditions, as well as for primary biliary cholangitis and pyoderma gangrenosum; and APD371, which is in Phase II trial ...

    Comment?